Conquering Diseases

A Study for Patients with Higher-Risk Myelodysplastic Syndromes (Abbvie 522)


This study is looking at a new experimental medication for men and women with Myelodysplastic Syndromes (MDS).


The purpose of this study is to evaluate the safety and effectiveness of an investigational drug, alone and in combination with a second, approved drug in subjects with MDS that have relapsed or need continued treatment.

What we're hoping for

The purpose of this study is to find out if patients with MDS respond better or worse to the study drug, and to find out more information on how MDS and related conditions develop and progress and how they can be diagnosed, monitored, or treated.

Additional Information Identifier: NCT02966782

 Principal Investigator

Muthalagu  Ramanathan, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655